| 000 | 01540 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511205626.0 | ||
| 264 | 0 | _c19910703 | |
| 008 | 199107s 0 0 eng d | ||
| 022 | _a0378-7346 | ||
| 024 | 7 |
_a10.1159/000293106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTerao, T | |
| 245 | 0 | 0 |
_aThe relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. _h[electronic resource] |
| 260 |
_bGynecologic and obstetric investigation _c1991 |
||
| 300 |
_a74-85 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntifibrinolytic Agents _xanalysis |
| 650 | 0 | 4 |
_aAntithrombin III _xanalysis |
| 650 | 0 | 4 |
_aBlood Coagulation _xphysiology |
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
| 650 | 0 | 4 |
_aFibrinolysin _xanalysis |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xanalysis |
| 650 | 0 | 4 |
_aPre-Eclampsia _xblood |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aalpha-2-Antiplasmin |
| 700 | 1 | _aMaki, M | |
| 700 | 1 | _aIkenoue, T | |
| 700 | 1 | _aGotoh, K | |
| 700 | 1 | _aMurata, M | |
| 700 | 1 | _aIwasaki, H | |
| 700 | 1 | _aShibata, J | |
| 700 | 1 | _aNakabayashi, M | |
| 700 | 1 | _aMuraoka, M | |
| 700 | 1 | _aTakeda, Y | |
| 773 | 0 |
_tGynecologic and obstetric investigation _gvol. 31 _gno. 2 _gp. 74-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000293106 _zAvailable from publisher's website |
| 999 |
_c1834259 _d1834259 |
||